CSL-Ltd-CSLAX-Deep-dive-into-Pipeline-A12-to-Target-Price.pdf
This is a recently released Goldman Sachs report detailing the current R&D landscape for CSL. It provides the rational behind their $312 target price. Of course with all broker reports you have to take with a grain of salt. However, they explore each of the 15 projects in/near active
development, assessing the data and the likely regulatory pathway and financial impact. Awesome read for anyone wanted a breakdown of the underlying molecules, the target markets and the overall opportunities. I feel sorry for the intern Riashad Monjur, who gets a brief shoutout for probably writing the whole thing. As usual DYOR.
CSL has more upside..., page-107
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$301.51 |
Change
1.100(0.37%) |
Mkt cap ! $145.9B | |||
| Open | High | Low | Value | Volume |
| $301.49 | $303.53 | $301.43 | $205.6M | 681.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 518 | $301.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $301.64 | 1548 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |